Roles for NF-κB and c-Fos in osteoclasts

Journal of Bone and Mineral Metabolism

Volumn 23, Issue SUPPL. 1, 2005, Pages 11-15

  Boyce, Brendan F ^a   Yamashita, Teruhito ^a   Yao, Zhenqiang ^a   Zhang, Qian ^a   Li, Fang ^a   Xing, Lianping ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Osteoblasts; Osteoclasts; Regulation

Indexed keywords

CYTOKINE; ESTROGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN C FOS;

ANIMAL; CELL DIFFERENTIATION; HUMAN; METABOLISM; OSTEITIS; OSTEOCLAST; OSTEOLYSIS; PHYSIOLOGY; POSTMENOPAUSE OSTEOPOROSIS; REVIEW;

ANIMALS; BONE RESORPTION; CELL DIFFERENTIATION; CYTOKINES; ESTROGENS; HUMANS; NF-KAPPA B; OSTEITIS; OSTEOCLASTS; OSTEOPOROSIS, POSTMENOPAUSAL; PROTO-ONCOGENE PROTEINS C-FOS;

EID: 23844489850     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03026317     Document Type: Review

References (62)

1. Rasmussen H, Bordier P (1974) The Physiological Basis of Metabolic Bone Disease. William & Wilkins, Baltimore, USA, pp 1-314
2. AJ Kahn DJ Simmons 1975 Investigation of cell lineage in bone using a chimaera of chick and quial embryonic tissue Nature (Lond) 258 325 327
3. DG Walker 1975 Bone resorption restored in osteopetrotic mice by transplants of normal bone marrow and spleen cells Science 190 784 785
4. LG Raisz RA Luben GR Mundy JW Dietrich JE Horton CL Trummel 1975 Effect of osteoclast activating factor from human leukocytes on bone metabolism J Clin Invest 56 408 413
5. P Soriano C Montgomery R Geske A Bradley 1991 Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice Cell 64 693 702
6. c-src expression for osteoclasts to form ruffled borders and resorb bone in mice J Clin Invest 90 1622 1627
7. G Franzoso L Carlson L Xing L Poljak EW Shores KD Brown A Leonardi T Tran BF Boyce U Siebenlist 1997 Requirement for NF-kappaB in osteoclast and B-cell development Genes Dev 11 3482 3496
8. V Iotsova J Caamano J Loy A Lewin R Bravo 1997 Osteopetrosis in mice lacking NF-κB1 and NF-KB2 Nat Med 3 1285 1289
9. WS Simonet DL Lacey CR Dunstan 1997 Osteoprotegerin: a novel secreted protein involved in the regulation of bone density Cell 89 309 319
10. DL Lacey E Timms HL Tan 1998 Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation Cell 93 165 176
11. J Li I Sarosi XQ Yan 2000 RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism Proc Natl Acad Sci U S A 97 1566 1571
12. WC Dougall M Glaccum K Charrier KR Brasel T Smedt E Daro J Smith ME Tometsko CR Maliszewski A Armstrong V Shen S Bain D Cosman D Anderson PJ Morrissey JP Schuh 1999 RANK is essential for osteoclast and lymph node development Genes Dev 13 2412 2424
13. YY Kong H Yoshida I Sarosi HL Tan E Timms C Capparelli S Morony AJ Oliveira-dos-Santos G Van A Itie W Khoo A Wakeham CR Dunstan DL Lacey TW Mak WJ Boyle JM Penninger 1999 OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis Nature (Lond) 397 315 323
14. YY Kong U Feige I Sarosi 1999 Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand Nature (Lond) 402 304 309
15. I Itonaga Y Fujikawa A Sabokbar DW Murray NA Athanasou 2000 Rheumatoid arthritis synovial macrophage-osteoclast differentiation is osteoprotegerin ligand-dependent J Pathol 192 97 104
16. LC Hofbauer S Khosla CR Dunstan DL Lacey TC Spelsberg BL Riggs 1999 Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells Endocrinology 140 4367 4370
17. LC Hofbauer CR Dunstan TC Spelsberg BL Riggs S Khosla 1998 Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines Biochem Biophys Res Commun 250 776 781
18. GJ Atkins P Kostakis B Pan A Farrugia S Gronthos A Evdokiou K Harrison DM Findlay AC Zannettino 2003 RANKL expression is related to the differentiation state of human osteoblasts J Bone Miner Res 18 1088 1098
19. WJ Boyle WS Simonet DL Lacey 2003 Osteoclast differentiation and activation Nature (Lond) 423 337 342
20. MS Hayden S Ghosh 2004 Signaling to NF-kappa B Genes Dev 18 2195 2224
21. L Xing TP Bushnell L Carlson Z Tai M Tondravi U Siebenlist F Young BF Boyce 2002 NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis J Bone Miner Res 17 1200 1210
22. U Siebelist G Franzoso K Brown 1994 Structure, regulation and function of NF-κB Annu Rev Cell Biol 10 405 455
23. A Baldwin 2001 The transcription factor NF-κB and human disease J Clin Invest 107 3 6
24. DV Novack L Yin A Hagen-Stapleton RD Schreiber DV Goeddel FP Ross SL Teitelbaum 2003 The IkappaB function of NF- kappaB2 p100 controls stimulated osteoclastogenesis J Exp Med 198 771 781
25. E Shaulian M Karin 2002 AP-1 as a regulator of cell life and death Nat Cell Biol 4 E131 E136
26. Z-Q Wang C OVitt AE Grigoriadis U Mohle-Steinlein U Ruther EF Wagner 1992 Bone and haematopoietic defects in mice lacking c-Fos Nature (Lond) 360 741 745
27. GR Crabtree EN Olson 2002 NFAT signaling: choreographing the social lives of cells Cell 109 S67 S79
28. A Rao C Luo PG Hogan 1997 Transcription factors of the NFAT family: regulation and function Annu Rev Immunol 15 707 747
29. H Takayanagi S Kim T Koga H Nishina M Isshiki H Yoshida A Saiura M Isobe T Yokochi J Inoue EF Wagner TW Mak T Kodama T Taniguchi 2002 Induction and activation of the transcription factor NFATcl (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts Dev Cell 3 889 901
30. T Koga M Inui K Inoue S Kim A Suematsu E Kobayashi T Iwata H Ohnishi T Matozaki T Kodama T Taniguchi H Takayanagi T Takai 2004 Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis Nature (Lond) 428 758 763
31. N Ishida K Hayashi M Hoshijima T Ogawa S Koga Y Miyatake M Kumegawa T Kimura T Takeya 2002 Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator J Biol Chem 277 41147 41156
32. H Hirotani NA Tuohy JT Woo PH Stern NA Clipstone 2004 The calcineurin/nuclear factor of activated T cells signaling pathway regulates osteoclastogenesis in RAW264.7 cells J Biol Chem 279 13984 13992
33. K Matsuo DL Galson C Zhao L Peng C Laplace KZ Wang MA Bachler H Amano H Aburatani H Ishikawa EF Wagner 2004 Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos J Biol Chem 279 26475 26480
34. K Igarashi H Hirotani JT Woo PH Stern 2004 Cyclosporine A and FK506 induce osteoclast apoptosis in mouse bone marrow cell cultures Bone 35 47 56
35. F Ikeda R Nishimura T Matsubara S Tanaka J Inoue SV Reddy K Hata K Yamashita T Hiraga T Watanabe T Kukita K Yoshioka A Rao T Yoneda 2004 Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation J Clin Invest 114 475 484
36. GG McGill M Horstmann HR Widlund J Du G Motyckova EK Nishimura YL Lin S Ramaswamy W Avery HF Ding SA Jordan IJ Jackson SJ Korsmeyer TR Golub DE Fisher 2002 Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability Cell 109 707 718
37. V Rajapurohitam N Chalhoub N Benachenhou L Neff R Baron J Vacher 2001 The mouse osteopetrotic grey-lethal mutation induces a defect in osteoclast maturation/function Bone 28 513 523
38. GA Partington K Fuller TJ Chambers M Pondel 2004 Mitf- PU.l interactions with the tartrate-resistant acid phosphatase gene promoter during osteoclast differentiation Bone 34 237 245
39. M Gowen F Lazner R Dodds R Kapadia J Feild M Tavaria I Bertoncello F Drake S Zavarselk I Tellis P Hertzog C Debouck I Kola 1999 Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization J Bone Miner Res 14 1654 1663
40. LC Hofbauer AE Heufelder 1999 Osteopetrosis in cathepsin K-deficient mice Eur J Endocrinol 140 376 377
41. AR Hayman SJ Jones A Boyde D Foster WH Colledge MB Carlton MJ Evans TM Cox 1996 Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteopetrosis Development (Camb) 122 3151 3162
42. N Chalhoub N Benachenhou V Rajapurohitam M Pata M Ferron A Frattini A Villa J Vacher 2003 Grey-lethal mutation induces severe malignant autosomal recessive osteopetrosis in mouse and human Nat Med 9 399 406
43. BF Boyce 2003 Bad bones, grey hair, one mutation Nat Med 9 395 396
44. B Wong D Besser N Kim J Arron M Vologodskaia H Hanafusa Y Choi 1999 TRANCE, a TNF family member, activates Akt/ PKB through a signaling complex involving TRAF6 and c-Src Cell 4 1041 1049
45. L Xing AM Venegas A Chen L Garrett-Beal BF Boyce HE Varmus PL Schwartzberg 2001 Genetic evidence for a role for Src family kinases in TNF family receptor signaling and cell survival Genes Dev 15 241 253
46. I Recchia N Rucci A Funari S Migliaccio A Taranta M Longo M Kneissel M Susa D Fabbro A Teti 2004 Reduction of c-Src activity by substituted 5,7-diphenyl-pyrrolo[2,3-d]-pyrimidines induces osteoclast apoptosis in vivo and in vitro. Involvement of ERK1/2 pathway Bone 34 65 79
47. T Miyazaki H Katagiri Y Kanegae H Takayanagi Y Sawada A Yamamoto MP Pando T Asano IM Verma H Oda K Nakamura S Tanaka 2000 Reciprocal role of ERK and NF-kappaB pathways in survival and activation of osteoclasts J Cell Biol 148 333 342
48. A Gingery E Bradley A Shaw MJ Oursler 2003 Phosphatidylinositol 3-kinase coordinately activates the MEK/ ERK and AKT/NFkappaB pathways to maintain osteoclast survival J Cell Biochem 89 165 179
49. H Takayanagi S Kim K Matsuo H Suzuki T Suzuki K Sato T Yokochi H Oda K Nakamura N Ida EF Wagner T Taniguchi 2002 RANKL maintains bone homeostasis through c-Fosdependent induction of interferon-beta [see comment] Nature (Lond) 416 744 749
50. GS Firestein 2003 Evolving concepts of rheumatoid arthritis Nature (Lond) 423 356 361
51. Z Yao P Li Q Zhang EM Schwarz L Ma P Keng BF Boyce LP Xing 2004 TNF increases bone marrow osteoclast precursor numbers by stimulating their proliferation and differentiation through up-regulation of c-Fms expression J Bone Miner Res 19 S171 S171
52. P Li EM Schwarz RJ O'Keefe L Ma RJ Looney CT Ritchlin BF Boyce L Xing 2004 Systemic tumor necrosis factor alpha mediates an increase in peripheral CD11b high osteoclast precursors in tumor necrosis factor alpha-transgenic mice Arthritis Rheum 50 265 276
53. P Li EM Schwarz RJ O'Keefe L Ma BF Boyce L Xing 2004 RANK signaling is not required for TNFa-mediated increase in CD11bhi osteoclast precursors, but is essential for mature osteoclast formation in TNFa-mediated inflammatory arthritis J Bone Miner Res 19 207 213
54. T Yamashita L Xing P Li EM Schwarz WC Dougall BF Boyce 2002 c-Fos over-expression induces osteoclastogenesis independent of RANK signaling J Bone Miner Res 17 S131 S131
55. T Yamashita L Xing K Matsuo EF Wagner BF Boyce 2003 Treatment of c-Fos over-expressing osteoclast precursors with cytokines induces osteoclastformation and abrogates bisphosphonate-induced osteoclast apoptosis J Bone Miner Res 18 S17 S17
56. DE Hughes A Dai JC Tiffee HH Li GR Mundy BF Boyce 1996 Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-13 Nat Med 2 1132 1136
57. RM Locklin S Khosla RT Turner BL Riggs 2003 Mediators of the biphasic responses of bone to intermittent and continuously administered parathyroid hormone J Cell Biochem 89 180 190
58. DM Black SL Greenspan KE Ensrud L Palermo JA McGowan TF Lang P Garnero ML Bouxsein JP Bilezikian CJ Rosen 2003 The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis N Engl J Med 349 1207 1215
59. SV Reddy N Kurihara C Menaa GD Roodman 2001 Paget's disease of bone: a disease of the osteoclast Rev Endocr Metab Disord 2 195 201
60. TL Johnson-Pais JH Wisdom KS Weldon JD Cody MF Hansen FR Singer RJ Leach 2003 Three novel mutations in SQSTM1 identified in familial Paget's disease of bone J Bone Miner Res 18 1748 1753
61. LJ Hocking GJ Lucas A Daroszewska J Mangion M Olavesen T Cundy GC Nicholson L Ward ST Bennett W Wuyts W Van Hul SH Ralston 2002 Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget's disease Hum Mol Genet 11 2735 2739
62. AE Hughes SH Ralston J Marken C Bell H MacPherson RG Wallace W van Hul MP Whyte K Nakatsuka L Hovy DM Anderson 2000 Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis Nat Genet 24 45 48